Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Weller

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Nature Biotechnology|May 9, 2006
In silico pharmacogenetics of warfarin metabolismYingying Guo, Paul Weller, Erin Farrell, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2004
Rational design of 6-methylsulfonylindoles as selective cyclooxygenase-2 inhibitorsJeffrey A Campbell, Viola Bordunov, Chris A Broka, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2009
Spiropiperidine CCR5 antagonistsDavid M Rotstein, Stephen D Gabriel, Ferenc Makra, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2010
Novel hexahydropyrrolo[3,4-c]pyrrole CCR5 antagonistsDavid M Rotstein, Chris R Melville, Fernando Padilla, et al.
Genome Research|November 20, 2009
An integrative genomic analysis identifies Bhmt2 as a diet-dependent genetic factor protecting against acetaminophen-induced liver toxicityHong-Hsing Liu, Peng Lu, Yingying Guo, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
3-Amino-pyrazolo[3,4-d]pyrimidines as p38α kinase inhibitors: design and development to a highly selective leadMichael Soth, Sarah Abbot, Allassan Abubakari, et al.
Journal of Medicinal Chemistry|October 17, 2003
Design and synthesis of 4-azaindoles as inhibitors of p38 MAP kinaseAlejandra Trejo, Humberto Arzeno, Michelle Browner, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2013
Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): kinase profiling guided optimization of a 1,2,3-benzotriazole leadWylie S Palmer, Muzaffar Alam, Humberto B Arzeno, et al.
Journal of Medicinal Chemistry|March 3, 2006
Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]methanone (RO3201195), an orally bioavailable and highly selective inhibitor of p38 MAP kinaseDavid M Goldstein, Tom Alfredson, Jay Bertrand, et al.
Journal of Medicinal Chemistry|March 8, 2011
Discovery of 6-(2,4-difluorophenoxy)-2-[3-hydroxy-1-(2-hydroxyethyl)propylamino]-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one (pamapimod) and 6-(2,4-difluorophenoxy)-8-methyl-2-(tetrahydro-2H-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (R1487) as orally bioavailable and highly selective inhibitors of p38α mitogen-activated protein kinaseDavid M Goldstein, Michael Soth, Tobias Gabriel, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nature Biotechnology|May 9, 2006
In silico pharmacogenetics of warfarin metabolismYingying Guo, Paul Weller, Erin Farrell, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2004
Rational design of 6-methylsulfonylindoles as selective cyclooxygenase-2 inhibitorsJeffrey A Campbell, Viola Bordunov, Chris A Broka, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2009
Spiropiperidine CCR5 antagonistsDavid M Rotstein, Stephen D Gabriel, Ferenc Makra, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2010
Novel hexahydropyrrolo[3,4-c]pyrrole CCR5 antagonistsDavid M Rotstein, Chris R Melville, Fernando Padilla, et al.
Genome Research|November 20, 2009
An integrative genomic analysis identifies Bhmt2 as a diet-dependent genetic factor protecting against acetaminophen-induced liver toxicityHong-Hsing Liu, Peng Lu, Yingying Guo, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
3-Amino-pyrazolo[3,4-d]pyrimidines as p38α kinase inhibitors: design and development to a highly selective leadMichael Soth, Sarah Abbot, Allassan Abubakari, et al.
Journal of Medicinal Chemistry|October 17, 2003
Design and synthesis of 4-azaindoles as inhibitors of p38 MAP kinaseAlejandra Trejo, Humberto Arzeno, Michelle Browner, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2013
Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): kinase profiling guided optimization of a 1,2,3-benzotriazole leadWylie S Palmer, Muzaffar Alam, Humberto B Arzeno, et al.
Journal of Medicinal Chemistry|March 3, 2006
Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]methanone (RO3201195), an orally bioavailable and highly selective inhibitor of p38 MAP kinaseDavid M Goldstein, Tom Alfredson, Jay Bertrand, et al.
Journal of Medicinal Chemistry|March 8, 2011
Discovery of 6-(2,4-difluorophenoxy)-2-[3-hydroxy-1-(2-hydroxyethyl)propylamino]-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one (pamapimod) and 6-(2,4-difluorophenoxy)-8-methyl-2-(tetrahydro-2H-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (R1487) as orally bioavailable and highly selective inhibitors of p38α mitogen-activated protein kinaseDavid M Goldstein, Michael Soth, Tobias Gabriel, et al.
Pageof 2